Who
Jeffrey T. Walsh
Director
Company insider
Files Form 4 as: Director, Tenaya Therapeutics; Chief Strategy Officer, bluebird bio.
In numbers
- Trades disclosed
- 275
- Buys
- 0
- Sells
- 57
- Bought
- $0
- Sold
- $45.1M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 10 Jan 2014
- Last trade
- 28 May 2026
- Last filed
- 29 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 May 2026filed 29 May 2026 | TNYA Tenaya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —120,000 at $0.00 | filing |
| 28 May 2026filed 29 May 2026 | TNYA Tenaya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —120,000 at $0.00 | filing |
| 29 May 2025filed 30 May 2025 | TNYA Tenaya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —107,400 at $0.00 | filing |
| 18 Oct 2024filed 21 Oct 2024 | TNYA Tenaya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,000 at $0.00 | filing |
| 9 Jun 2023filed 12 Jun 2023 | TNYA Tenaya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,532 at $0.00 | filing |
| 10 Jun 2022filed 13 Jun 2022 | TNYA Tenaya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —39,727 at $0.00 | filing |
| 20 Aug 2019filed 21 Aug 2019 | bluebird biooption or derivative | SEC FORM 4 Code M | —500 at $0.00 | filing |
| 20 Aug 2019filed 21 Aug 2019 | bluebird bio | SEC FORM 4 Code M | $12K500 at $24.47 | filing |
| 20 Aug 2019filed 21 Aug 2019 | bluebird bio | SEC FORM 4 Sold | $62K500 at $124.00 | filing |
| 18 Jun 2019filed 20 Jun 2019 | bluebird biooption or derivative | SEC FORM 4 Code M | —100 at $0.00 | filing |
| 18 Jun 2019filed 20 Jun 2019 | bluebird bio | SEC FORM 4 Code M | $2,447100 at $24.47 | filing |
| 18 Jun 2019filed 20 Jun 2019 | bluebird bio | SEC FORM 4 Sold | $13K100 at $126.12 | filing |
| 10 Jun 2019filed 12 Jun 2019 | bluebird biooption or derivative | SEC FORM 4 Code M | —1,400 at $0.00 | filing |
| 10 Jun 2019filed 12 Jun 2019 | bluebird bio | SEC FORM 4 Code M | $34K1,400 at $24.47 | filing |
| 10 Jun 2019filed 12 Jun 2019 | bluebird bio | SEC FORM 4 Sold | $150K1,200 at $125.19 | filing |
| 10 Jun 2019filed 12 Jun 2019 | bluebird bio | SEC FORM 4 Sold | $25K200 at $126.96 | filing |
| 10 May 2019filed 14 May 2019 | bluebird biooption or derivative | SEC FORM 4 Code M | —1,500 at $0.00 | filing |
| 10 May 2019filed 14 May 2019 | bluebird bio | SEC FORM 4 Code M | $37K1,500 at $24.47 | filing |
| 10 May 2019filed 14 May 2019 | bluebird bio | SEC FORM 4 Sold | $26K200 at $131.11 | filing |
| 10 May 2019filed 14 May 2019 | bluebird bio | SEC FORM 4 Sold | $146K1,100 at $132.38 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.